Postmarket Problems: FDA Struggles To Achieve Manufacturer Compliance
This article was originally published in The Gray Sheet
Executive Summary
CDRH's cardiovascular review division has faced resistance from PMA sponsors in complying with post-approval study requirements that involve new patient registries, an official from the division reported May 9 at the North American Society of Pacing and Electrophysiology annual meeting
You may also be interested in...
UK Medical Devices Agency Issues AAA, Breast Implant Device Updates
Endovascualar prosthesis treatment outcomes remain contingent on factors such as aneurysmal remodeling and patients' vascular anatomy, the UK's Medical Devices Agency concludes in a 1May update on devices for abdominal and thoracic aortic aneurysms
UK Medical Devices Agency Issues AAA, Breast Implant Device Updates
Endovascualar prosthesis treatment outcomes remain contingent on factors such as aneurysmal remodeling and patients' vascular anatomy, the UK's Medical Devices Agency concludes in a 1May update on devices for abdominal and thoracic aortic aneurysms
AneuRx Is First Sec. 522 Study Ordered Under Proposed Rule; More To Follow
Medtronic's AneuRx abdominal aortic aneurysm (AAA) endovascular graft will aim to compare long-term outcomes of the device's IDE cohort with patients who received the implant postmarket.